Widening the Funnel
Where AI Doesn’t Change the Math — Part B Part A argued that AI-assisted diligence widens the top of the in-licensing funnel. More opportunities can get real evaluation without proportionally…
Where AI Doesn’t Change the Math — Part B Part A argued that AI-assisted diligence widens the top of the in-licensing funnel. More opportunities can get real evaluation without proportionally…
How AI Changes the Math of In-Licensing — Part A Every licensing executive has seen some version of this chart. AbbVie disclosed its own numbers a few years back: roughly…
Will AI create more assets than pharma can absorb? AI is often discussed as a solution to pharmaceutical research and development productivity. It may be. Certainly Big Pharma thinks so,…
After ~six months of integrating AI into our workflows at Lacerta Bio (plus building a few custom tools for ourselves and our clients), I've developed what I call the "intern-to-partner…
Introduction In Part I of this series, we introduced the idea that drug candidates emerging from artificial intelligence may have to be valued differently than those emerging from more traditional…
Introduction In Part I of this series, we introduced the idea that drug candidates emerging from artificial intelligence may have to be valued differently than those emerging from more traditional…
Introduction In Part I of this series, we introduced the idea that drug candidates emerging from artificial intelligence may have to be valued differently than those emerging from more traditional…
Ownership and Inventorship Ambiguity Introduction In Part I of this series, we introduced the idea that drug candidates emerging from artificial intelligence may have to be valued differently than those…
A Five-Part Series on AI Drug Discovery Valuation Challenges Introduction I have no idea. That was my brilliant, insightful, memorable, put this on a t-shirt answer to the question posed…
Introduction Part I of this article proposed a framework to help guide the discussion around repurposing, which we define very broadly. Now, in Part II, we extend the framework and…